Knott David M

13F filer · CIK 0000808722

Last filed Nov 12, 2021

Inactive · not filing 13F

13F portfolio value$275MU.S. long equity reported on 13F

Positions11113 new · 15 closed

Net flow last quarter-$19.9MBuys minus sells

Top 10 positions weight41.6%Concentration

Holdings

13F · last 4 quarters free

Scroll for earlier quarters

Company	Value	% of portfolio	% of company	POSITION CHANGE qoq %	First reported
Q3 2021Reported Nov 12, 2021111 positions
CLMTCalumet, Inc.	$28.2M	10.25%	Not reported	+13.1%	Q1 2018
APOApollo Global Management, Inc.	$15.4M	5.60%	Not reported	-16.7%	Q2 2017
GOOGAlphabet Inc.	$14.9M	5.42%	Not reported	Not reported	Q1 2019
LGNDLigand Pharmaceuticals Inc	$10.4M	3.80%	0.45%	Not reported	Q3 2016
UPLDUpland Software, Inc.	$10M	3.65%	0.98%	Not reported	Q4 2017
MITAColiseum Acquisition Corp.	$9.56M	3.47%	Not reported	New	Q3 2021
KDMNKadmon Holdings, Inc.	$8.62M	3.13%	0.56%	+18.1%	Q3 2019
MDWTMidwest Holding Inc.	$6.61M	2.40%	4.55%	+3.0%	Q3 2020
GREEVulcan Infrastructure & Power Inc.	$5.72M	2.08%	Not reported	New	Q3 2021
TWLVTwelve Seas Investment Co III/Cayman	$5M	1.82%	Not reported	Not reported	Q2 2021
PFEPfizer Inc	$4.93M	1.79%	0.00%	-4.5%	Q3 2016
GLHAGlass Houses Acquisition Corp.	$4.89M	1.78%	Not reported	Not reported	Q2 2021
FSKFS KKR Capital Corp	$4.4M	1.60%	0.16%	-49.4%	Q2 2020
KWKennedy-Wilson Holdings, Inc.	$4.39M	1.60%	0.15%	Not reported	Q2 2020
EBCEastern Bankshares, Inc.	$3.86M	1.40%	0.10%	-5.0%	Q4 2020
REGNRegeneron Pharmaceuticals, Inc.	$3.63M	1.32%	0.01%	Not reported	Q2 2021
LOKMLive Oak Mobility Acquisition Corp.	$3.48M	1.27%	Not reported	Not reported	Q2 2021
BRIVB. Riley Principal 250 Merger Corp.	$3.4M	1.23%	Not reported	New	Q3 2021
KAIRKairos Acquisition Corp.	$3.34M	1.21%	Not reported	Not reported	Q1 2021
DNMRDanimer Scientific, Inc.	$3.27M	1.19%	Not reported	Not reported	Q4 2020
KKRKKR & Co. Inc.	$3.04M	1.11%	0.01%	-50.0%	Q1 2020
AVDLAvadel Pharmaceuticals PLC	$2.96M	1.07%	0.52%	-1.0%	Q4 2016
UTHRUNITED THERAPEUTICS Corp	$2.82M	1.03%	0.03%	Not reported	Q1 2021
JPMJPMorgan Chase & Co	$2.74M	1.00%	0.00%	-7.9%	Q3 2016
BMYBristol Myers Squibb Co	$2.51M	0.91%	0.00%	-2.3%	Q1 2017
ABAlliancebernstein Holding L.P.	$2.5M	0.91%	0.05%	Not reported	Q3 2016
HZNPHorizon Therapeutics Public Ltd Co	$2.19M	0.80%	0.01%	-37.5%	Q4 2017
HZACHorizon Acquisition Corporation	$2.1M	0.76%	Not reported	Not reported	Q4 2020
EIGREiger Biopharmaceuticals, Inc.	$2.09M	0.76%	0.92%	+9.1%	Q3 2017
PMGMAEON Biopharma, Inc.	$1.97M	0.72%	Not reported	Not reported	Q1 2021
MSACMedicus Sciences Acquisition Corp.	$1.95M	0.71%	Not reported	New	Q3 2021
INVAInnoviva, Inc.	$1.93M	0.70%	0.17%	+141.2%	Q2 2021
ZGNXZogenix, Inc.	$1.89M	0.69%	0.22%	Not reported	Q3 2017
INCYIncyte Corp	$1.82M	0.66%	0.01%	New	Q3 2021
BRPMAlta Equipment Group Inc.	$1.73M	0.63%	Not reported	-66.4%	Q2 2021
TGTXTG Therapeutics, Inc.	$1.65M	0.60%	0.03%	-1.6%	Q2 2020
CHRSCoherus Oncology, Inc.	$1.65M	0.60%	0.13%	+2.9%	Q2 2017
QUREuniQure N.V.	$1.5M	0.54%	0.10%	Not reported	Q4 2019
XENEXenon Pharmaceuticals Inc.	$1.44M	0.52%	0.23%	-32.8%	Q3 2017
AUPHAurinia Pharmaceuticals Inc.	$1.39M	0.51%	0.05%	-61.8%	Q1 2019
VKTXViking Therapeutics, Inc.	$1.31M	0.47%	0.27%	Not reported	Q4 2017
GILDGilead Sciences, Inc.	$1.08M	0.39%	0.00%	Not reported	Q3 2016
RHPRyman Hospitality Properties, Inc.	$1.04M	0.38%	0.02%	Not reported	Q3 2016
VZVerizon Communications Inc	$972K	0.35%	0.00%	+1.6%	Q3 2016
MDLZMondelez International, Inc.	$931K	0.34%	0.00%	+0.6%	Q3 2016
CDTXCidara Therapeutics, Inc.	$930K	0.34%	0.84%	Not reported	Q2 2019
MRNSMarinus Pharmaceuticals, Inc.	$924K	0.34%	0.22%	Not reported	Q4 2020
ABBVAbbVie Inc.	$863K	0.31%	0.00%	Not reported	Q3 2016
JNJJohnson & Johnson	$840K	0.31%	0.00%	-14.5%	Q3 2016
DDDuPont de Nemours, Inc.	$826K	0.30%	0.00%	+0.4%	Q2 2019

Q2 2021Reported Aug 13, 2021113 positions
CLMTCalumet, Inc.	$21.7M	7.70%	Not reported	+10.8%	Q1 2018
APOApollo Global Management, Inc.	$18.7M	6.63%	Not reported	Not reported	Q2 2017
MITAUColiseum Acquisition Corp.	$14.7M	5.22%	Not reported	New	Q2 2021
GOOGAlphabet Inc.	$14M	4.99%	Not reported	Not reported	Q1 2019
UPLDUpland Software, Inc.	$12.4M	4.39%	0.99%	Not reported	Q4 2017
LGNDLigand Pharmaceuticals Inc	$9.84M	3.50%	0.45%	Not reported	Q3 2016
FSKFS KKR Capital Corp	$8.5M	3.02%	0.32%	Not reported	Q2 2020
MDWTMidwest Holding Inc.	$6.47M	2.30%	4.41%	+10.0%	Q3 2020
PSTHPershing Square Tontine Holdings, Ltd.	$6.26M	2.22%	Not reported	New	Q2 2021
KKRKKR & Co. Inc.	$5.92M	2.11%	0.02%	Not reported	Q1 2020
BRPMAlta Equipment Group Inc.	$5.22M	1.85%	Not reported	New	Q2 2021
DNMRDanimer Scientific, Inc.	$5.01M	1.78%	Not reported	Not reported	Q4 2020
TWLVTwelve Seas Investment Co III/Cayman	$4.97M	1.77%	Not reported	New	Q2 2021
GLHAGlass Houses Acquisition Corp.	$4.82M	1.71%	Not reported	New	Q2 2021
PFEPfizer Inc	$4.7M	1.67%	0.00%	Not reported	Q3 2016
KWKennedy-Wilson Holdings, Inc.	$4.17M	1.48%	0.15%	Not reported	Q2 2020
EBCEastern Bankshares, Inc.	$4.11M	1.46%	0.11%	Not reported	Q4 2020
LOKMLive Oak Mobility Acquisition Corp.	$3.53M	1.25%	Not reported	New	Q2 2021
REGNRegeneron Pharmaceuticals, Inc.	$3.35M	1.19%	0.01%	New	Q2 2021
KAIRKairos Acquisition Corp.	$3.35M	1.19%	Not reported	+32.2%	Q1 2021
KDMNKadmon Holdings, Inc.	$3.24M	1.15%	0.49%	+10.0%	Q3 2019
CNSTConstar International Inc	$3.11M	1.10%	Not reported	+7.0%	Q4 2020
HZNPHorizon Therapeutics Public Ltd Co	$3M	1.06%	0.01%	-21.2%	Q4 2017
BMYBristol Myers Squibb Co	$2.9M	1.03%	0.00%	-15.6%	Q1 2017
JPMJPMorgan Chase & Co	$2.83M	1.00%	0.00%	+17.5%	Q3 2016
UTHRUNITED THERAPEUTICS Corp	$2.75M	0.98%	0.03%	+5.5%	Q1 2021
XENEXenon Pharmaceuticals Inc.	$2.62M	0.93%	0.34%	-2.5%	Q3 2017
BRSLBrightstar Lottery PLC	$2.58M	0.92%	0.05%	Not reported	Q1 2019
EIGREiger Biopharmaceuticals, Inc.	$2.44M	0.87%	0.84%	+3.6%	Q3 2017
ABAlliancebernstein Holding L.P.	$2.35M	0.84%	0.05%	Not reported	Q3 2016
ZGNXZogenix, Inc.	$2.16M	0.77%	0.22%	+6.0%	Q3 2017
AUPHAurinia Pharmaceuticals Inc.	$2.14M	0.76%	0.13%	+6.5%	Q1 2019
HZONHorizon Acquisition Corporation II	$2.09M	0.74%	0.40%	New	Q2 2021
AVDLAvadel Pharmaceuticals PLC	$2.05M	0.73%	0.52%	+11.8%	Q4 2016
TGTXTG Therapeutics, Inc.	$1.95M	0.69%	0.04%	-3.1%	Q2 2020
PMGMAEON Biopharma, Inc.	$1.94M	0.69%	Not reported	Not reported	Q1 2021
MRNSMarinus Pharmaceuticals, Inc.	$1.46M	0.52%	0.22%	+34.7%	Q4 2020
QUREuniQure N.V.	$1.44M	0.51%	0.10%	+12.0%	Q4 2019
CHRSCoherus Oncology, Inc.	$1.38M	0.49%	0.13%	Not reported	Q2 2017
INSEInspired Entertainment, Inc.	$1.28M	0.45%	0.44%	New	Q2 2021
VKTXViking Therapeutics, Inc.	$1.25M	0.44%	0.27%	Not reported	Q4 2017
GILDGilead Sciences, Inc.	$1.07M	0.38%	0.00%	-69.6%	Q3 2016
IMVTImmunovant, Inc.	$1.03M	0.37%	0.10%	+185.3%	Q1 2021
JNJJohnson & Johnson	$1M	0.36%	0.00%	Not reported	Q3 2016
MDLZMondelez International, Inc.	$994K	0.35%	0.00%	Not reported	Q3 2016
VZVerizon Communications Inc	$992K	0.35%	0.00%	Not reported	Q3 2016
RHPRyman Hospitality Properties, Inc.	$980K	0.35%	0.02%	Not reported	Q3 2016
DDDuPont de Nemours, Inc.	$938K	0.33%	0.00%	Not reported	Q2 2019
ABBVAbbVie Inc.	$901K	0.32%	0.00%	-67.7%	Q3 2016
CDTXCidara Therapeutics, Inc.	$839K	0.30%	0.84%	Not reported	Q2 2019

Q1 2021Reported May 13, 2021103 positions
CLMTCalumet, Inc.	$17.4M	7.42%	Not reported	+7.6%	Q1 2018
UPLDUpland Software, Inc.	$14.2M	6.06%	1.00%	-26.2%	Q4 2017
APOApollo Global Management, Inc.	$14.1M	6.03%	Not reported	Not reported	Q2 2017
GOOGAlphabet Inc.	$11.6M	4.96%	Not reported	Not reported	Q1 2019
LGNDLigand Pharmaceuticals Inc	$11.4M	4.89%	0.45%	-69.8%	Q3 2016
FSKFS KKR Capital Corp	$7.84M	3.35%	0.32%	Not reported	Q2 2020
DNMRDanimer Scientific, Inc.	$7.55M	3.23%	Not reported	-60.0%	Q4 2020
MDWTMidwest Holding Inc.	$7.5M	3.21%	4.01%	+4.4%	Q3 2020
TWLVUTwelve Seas Investment Co III/Cayman	$5.07M	2.17%	Not reported	New	Q1 2021
KKRKKR & Co. Inc.	$4.89M	2.09%	0.02%	Not reported	Q1 2020
PFEPfizer Inc	$4.34M	1.86%	0.00%	Not reported	Q3 2016
KWKennedy-Wilson Holdings, Inc.	$4.24M	1.82%	0.15%	Not reported	Q2 2020
EBCEastern Bankshares, Inc.	$3.86M	1.65%	0.11%	Not reported	Q4 2020
HZNPHorizon Therapeutics Public Ltd Co	$3.74M	1.60%	0.02%	-4.7%	Q4 2017
GILDGilead Sciences, Inc.	$3.29M	1.41%	0.00%	-21.4%	Q3 2016
BMYBristol Myers Squibb Co	$3.25M	1.39%	0.00%	-1.9%	Q1 2017
KDMNKadmon Holdings, Inc.	$2.96M	1.27%	0.44%	+8.6%	Q3 2019
ABBVAbbVie Inc.	$2.68M	1.15%	0.00%	-24.4%	Q3 2016
XENEXenon Pharmaceuticals Inc.	$2.58M	1.10%	0.35%	-28.0%	Q3 2017
KAIRKairos Acquisition Corp.	$2.55M	1.09%	Not reported	New	Q1 2021
TGTXTG Therapeutics, Inc.	$2.51M	1.07%	0.04%	+2.4%	Q2 2020
AVDLAvadel Pharmaceuticals PLC	$2.47M	1.06%	0.47%	+213.9%	Q4 2016
EIGREiger Biopharmaceuticals, Inc.	$2.45M	1.05%	0.82%	-6.3%	Q3 2017
UTHRUNITED THERAPEUTICS Corp	$2.43M	1.04%	0.03%	New	Q1 2021
JPMJPMorgan Chase & Co	$2.36M	1.01%	0.00%	-22.5%	Q3 2016
ZGNXZogenix, Inc.	$2.3M	0.98%	0.21%	+4.4%	Q3 2017
HZACHorizon Acquisition Corporation	$2.08M	0.89%	Not reported	Not reported	Q4 2020
ABAlliancebernstein Holding L.P.	$2.02M	0.86%	0.05%	Not reported	Q3 2016
AUPHAurinia Pharmaceuticals Inc.	$2.01M	0.86%	0.12%	-12.8%	Q1 2019
CNSTConstar International Inc	$2.01M	0.86%	Not reported	+160.3%	Q4 2020
PMGMAEON Biopharma, Inc.	$1.95M	0.83%	Not reported	New	Q1 2021
BRSLBrightstar Lottery PLC	$1.73M	0.74%	0.05%	Not reported	Q1 2019
CHRSCoherus Oncology, Inc.	$1.46M	0.62%	0.14%	-2.0%	Q2 2017
QUREuniQure N.V.	$1.41M	0.60%	0.09%	+19.3%	Q4 2019
VKTXViking Therapeutics, Inc.	$1.32M	0.56%	0.27%	-4.6%	Q4 2017
VRCAVerrica Pharmaceuticals Inc.	$1.19M	0.51%	0.29%	+2.4%	Q2 2019
CDTXCidara Therapeutics, Inc.	$1.11M	0.47%	0.86%	Not reported	Q2 2019
VZVerizon Communications Inc	$1.03M	0.44%	0.00%	-3.3%	Q3 2016
ROCRUQualtek Services Inc.	$1M	0.43%	2.73%	New	Q1 2021
JNJJohnson & Johnson	$999K	0.43%	0.00%	Not reported	Q3 2016
RHPRyman Hospitality Properties, Inc.	$961K	0.41%	0.02%	Not reported	Q3 2016
DDDuPont de Nemours, Inc.	$936K	0.40%	0.00%	Not reported	Q2 2019
MRNSMarinus Pharmaceuticals, Inc.	$933K	0.40%	0.16%	+141.1%	Q4 2020
MDLZMondelez International, Inc.	$931K	0.40%	0.00%	Not reported	Q3 2016
KMBKimberly Clark Corp	$834K	0.36%	0.00%	Not reported	Q3 2017
DOWDow Inc.	$775K	0.33%	0.00%	Not reported	Q3 2016
KOCoca Cola Co	$707K	0.30%	0.00%	Not reported	Q3 2016
CNQCANADIAN NATURAL RESOURCES Ltd	$687K	0.29%	0.00%	Not reported	Q3 2016
TAt&T Inc.	$607K	0.26%	0.00%	-9.1%	Q3 2016
IBMInternational Business Machines Corp	$571K	0.24%	0.00%	Not reported	Q3 2016

Q4 2020Reported Feb 12, 202192 positions
LGNDLigand Pharmaceuticals Inc	$24.7M	11.16%	1.54%	Not reported	Q3 2016
UPLDUpland Software, Inc.	$18.7M	8.44%	1.36%	Not reported	Q4 2017
APOApollo Global Management, Inc.	$14.7M	6.65%	Not reported	Not reported	Q2 2017
DNMRDanimer Scientific, Inc.	$11.8M	5.32%	Not reported	New	Q4 2020
GOOGAlphabet Inc.	$9.81M	4.44%	Not reported	Not reported	Q1 2019
CLMTCalumet, Inc.	$8.28M	3.75%	Not reported	+30.9%	Q1 2018
MDWTMidwest Holding Inc.	$7.71M	3.49%	3.84%	+72.3%	Q3 2020
FSKFS KKR Capital Corp	$6.54M	2.96%	0.32%	Not reported	Q2 2020
PFEPfizer Inc	$4.41M	2.00%	0.00%	-9.1%	Q3 2016
LKQLKQ Corp	$4.23M	1.91%	0.04%	-20.0%	Q2 2018
KKRKKR & Co. Inc.	$4.05M	1.83%	0.02%	Not reported	Q1 2020
GILDGilead Sciences, Inc.	$3.78M	1.71%	0.01%	+489.5%	Q3 2016
KWKennedy-Wilson Holdings, Inc.	$3.76M	1.70%	0.15%	Not reported	Q2 2020
EIGREiger Biopharmaceuticals, Inc.	$3.63M	1.64%	0.87%	+7.2%	Q3 2017
ABBVAbbVie Inc.	$3.51M	1.59%	0.00%	-13.2%	Q3 2016
VXXBarclays Bank PLC	$3.36M	1.52%	Not reported	New	Q4 2020
EBCEastern Bankshares, Inc.	$3.26M	1.48%	0.11%	New	Q4 2020
BMYBristol Myers Squibb Co	$3.25M	1.47%	0.00%	+12.9%	Q1 2017
HZNPHorizon Therapeutics Public Ltd Co	$3.12M	1.41%	0.02%	+13.5%	Q4 2017
XENEXenon Pharmaceuticals Inc.	$3.08M	1.39%	0.57%	+13.0%	Q3 2017
KDMNKadmon Holdings, Inc.	$2.91M	1.32%	0.41%	+14.7%	Q3 2019
TGTXTG Therapeutics, Inc.	$2.64M	1.20%	0.04%	Not reported	Q2 2020
JPMJPMorgan Chase & Co	$2.54M	1.15%	0.00%	-13.4%	Q3 2016
AUPHAurinia Pharmaceuticals Inc.	$2.46M	1.11%	0.14%	+31.9%	Q1 2019
ZGNXZogenix, Inc.	$2.25M	1.02%	0.20%	Not reported	Q3 2017
MPLXMPLX LP	$2.17M	0.98%	0.01%	Not reported	Q1 2018
HZACHorizon Acquisition Corporation	$2.11M	0.95%	Not reported	New	Q4 2020
RTPJoby Aviation, Inc.	$2.04M	0.92%	Not reported	New	Q4 2020
BRSLBrightstar Lottery PLC	$1.82M	0.82%	0.05%	Not reported	Q1 2019
CHRSCoherus Oncology, Inc.	$1.77M	0.80%	0.14%	+2.2%	Q2 2017
ABAlliancebernstein Holding L.P.	$1.71M	0.77%	0.05%	Not reported	Q3 2016
ALXNAlexion Pharmaceuticals, Inc.	$1.65M	0.75%	0.00%	-12.1%	Q3 2020
BCRXBiocryst Pharmaceuticals Inc	$1.64M	0.74%	0.12%	-44.8%	Q1 2020
BDSIBiodelivery Sciences International Inc	$1.56M	0.70%	0.37%	-23.2%	Q1 2018
QUREuniQure N.V.	$1.27M	0.57%	0.08%	+12.9%	Q4 2019
VKTXViking Therapeutics, Inc.	$1.23M	0.56%	0.30%	Not reported	Q4 2017
VZVerizon Communications Inc	$1.08M	0.49%	0.00%	Not reported	Q3 2016
JNJJohnson & Johnson	$956K	0.43%	0.00%	-16.5%	Q3 2016
CNSTConstar International Inc	$950K	0.43%	Not reported	New	Q4 2020
MDLZMondelez International, Inc.	$930K	0.42%	0.00%	Not reported	Q3 2016
VRCAVerrica Pharmaceuticals Inc.	$881K	0.40%	0.30%	+66.0%	Q2 2019
DDDuPont de Nemours, Inc.	$861K	0.39%	0.00%	Not reported	Q2 2019
RHPRyman Hospitality Properties, Inc.	$840K	0.38%	0.02%	Not reported	Q3 2016
CDTXCidara Therapeutics, Inc.	$831K	0.38%	0.93%	+2.0%	Q2 2019
KMBKimberly Clark Corp	$809K	0.37%	0.00%	Not reported	Q3 2017
KOCoca Cola Co	$735K	0.33%	0.00%	Not reported	Q3 2016
DOWDow Inc.	$673K	0.30%	0.00%	Not reported	Q3 2016
TAt&T Inc.	$634K	0.29%	0.00%	Not reported	Q3 2016
AVDLAvadel Pharmaceuticals PLC	$581K	0.26%	0.15%	Not reported	Q4 2016
IBMInternational Business Machines Corp	$539K	0.24%	0.00%	Not reported	Q3 2016

Premium opens every quarter this fund has filed